Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
08/2004
08/26/2004WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors
08/26/2004WO2004071445A2 2-(aminomethyl)arylamide analgesics
08/26/2004WO2004050610A3 Modulators of melanocortin receptor
08/26/2004US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders
08/26/2004US20040167119 2-(aminomethyl) arylamide analgesics
08/25/2004EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/25/2004EP1448176A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
08/25/2004CN1163487C 4ªå&aryldecahydroisoquinoline compound and medical use thereof
08/24/2004US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/24/2004US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent
08/19/2004WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors
08/19/2004WO2004069162A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/19/2004WO2004058717A8 Isoquinolinone derivatives and their use as therapeutic agents
08/19/2004WO2003092688A3 Heterocyclic derivatives as opioid modulators
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004CA2513684A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/18/2004EP1447398A1 Retroviral protease inhibitors
08/18/2004CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
08/18/2004CN1162408C Process for preparing oxazolines from tetrahydrofurans
08/17/2004US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering
08/17/2004US6777422 Substituted tetrahydroisoquinolines as C5a receptor modulators
08/12/2004WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/12/2004WO2004067514A1 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
08/12/2004WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
08/12/2004WO2004043362A3 Acyl guanidine compounds and use thereof
08/12/2004WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
08/12/2004US20040158076 Tyrosine derivatives
08/12/2004US20040158062 Process for the production of quinazolines
08/12/2004US20040157866 Amide compounds
08/12/2004US20040157865 exhibit activity in animal models of hyperalgesia and colitis, and are useful for the treatment and prevention of pain conditions in humans including arthritis, and for the treatment of irritable-bowel syndrome
08/12/2004US20040157849 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/12/2004CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy
08/11/2004EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same
08/11/2004EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
08/11/2004CN1520702A Electroluminescent irisium compounds with fluorinated phenylpyridines, phenylpyridines and phenylquinolines and device made with such compounds
08/10/2004US6774086 Herbicides
08/05/2004WO2004065351A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
08/05/2004WO2004064842A1 Amide and ester matrix metalloproteinase inhibitors
08/05/2004WO2004064730A2 Compounds, compositions and methods
08/05/2004WO2003091688A3 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
08/05/2004WO2003077874A3 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
08/05/2004US20040152704 Bicyclic-substituted amines as histamine-3 receptor ligands
08/05/2004US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/05/2004CA2513349A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
08/05/2004CA2513115A1 Amide and ester matrix metalloproteinase inhibitors
08/04/2004EP1442095A1 Electroluminescent platinum compounds and devices made with such compounds
08/04/2004EP1442094A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
08/04/2004EP1442049A2 Substituted amino ketone compounds
08/04/2004EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands
08/04/2004CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
08/03/2004US6770657 Compounds
08/03/2004US6770656 Amine derivatives for the treatment of apoptosis
08/03/2004US6770639 Cell proliferative; autoimmune diseases; antiallergens; antiinflammatory agents; anticancer agents
08/03/2004CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
07/2004
07/29/2004WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents
07/29/2004WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004WO2004062601A2 Antibacterial agents
07/29/2004US20040147758 Compounds for treatment of AIDS with enzyme inhibitors
07/29/2004US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders
07/29/2004US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/29/2004US20040147503 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; antitumor agents; glomerulonephritis
07/29/2004US20040147454 Aspartyl protease inhibitors
07/29/2004CA2851462A1 Antibacterial agents
07/29/2004CA2512582A1 Antibacterial agents
07/29/2004CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/28/2004EP1440052A1 Benzamide derivatives as antagonists of orexin receptors
07/28/2004EP1137632B1 Thiourea inhibitors of herpes viruses
07/28/2004CN1516872A Optical data carrier that contains triazacyanine dye as light-absorbing compound in information layer
07/28/2004CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative
07/28/2004CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease
07/28/2004CN1159286C Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
07/27/2004US6768024 Triamine derivative melanocortin receptor ligands and methods of using same
07/27/2004US6767556 Hypotensive agents
07/22/2004WO2004060882A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
07/22/2004WO2004060876A1 Microporous structure of an organic metal complex
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004US20040143118 Chiral organic compounds and metal coordination complexes thereof
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/22/2004US20040142971 Benzothiophene compounds having antiinfective activity
07/22/2004US20040142964 Novel compounds
07/22/2004US20040142950 Amide and ester matrix metalloproteinase inhibitors
07/22/2004US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process.
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/21/2004EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR
07/21/2004EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
07/21/2004EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
07/21/2004EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
07/21/2004EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
07/21/2004CN1515002A Optical data carrier whose information layer contains light-absorbing compound having a number of chromophoric centers
07/21/2004CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity
07/21/2004CN1158274C Benzopyran-containing compounds and method for their use
07/21/2004CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease
07/15/2004WO2004058736A1 Ccr8 inhibitors
07/15/2004WO2004058718A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
07/15/2004WO2004058717A1 Isoquinolinone derivatives and their use as therapeutic agents
07/15/2004US20040138254 Central nervous system disorders; analgesics; headaches
07/15/2004US20040138205 Viricides; hepatitis virus
07/15/2004US20040138203 Antiserotonine agents
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 119